Skip to main content

Table 7 Hematological parameters of the animals after infection and after treatment

From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

Groups

After infection

After treatment

PCV (%)

RBC (106)

PCV (%)

RBC (106)

Group A

31.8 ± 1.79

8.44 ± 0.52

41 ± 1.15

10.54 ± 0.31

Group B

30.4 ± 2.07

8.51 ± 0.51

41 ± 1.83

9.90 ± 0.42

Group C

27 ± 11.90

7.97 ± 0.76

42 ± 2.90

10.50 ± 0.12

Group D

31.17 ± 3.60

7.87 ± 0.77

40.5 ± 3.11

10.39 ± 0.70

Group E

32 ± 3.65

8.51 ± 0.13

36.67 ± 3.21

10.49 ± 0.17

Group F

35.4 ± 3.71

7.08 ± 0.51

42.75 ± 2.22

10.36 ± 0.64

Group G

21.4 ± 1.95

5.05 ± 0.42

34.4 ± 2.30

9.32 ± 0.41

Group H

32.25 ± 3.30

6.60 ± 0.68

33.25 ± 2.75

8.76 ± 0.43

Group I

30.67 ± 2.50

7.75 ± 0.96

31.2 ± 1.92

7.75 ± 0.53

Group J

32.17 ± 2.71

6.76 ± 0.72

31.2 ± 1.30

7.5 ± 0.85

Group K

30.20 ± 1.48

6.87 ± 0.50

28.67 ± 3.05

7.70 ± 0.74

Group L

31.4 ± 1.67

7.10 ± 0.68

31.67 ± 1.53

7.44 ± 0.12

Group M

24 ± 2.97

6.12 ± 0.49

35.6 ± 3.65

8.41 ± 1.25

Group N

23.2 ± 3.03

5.67 ± 0.42

34.75 ± 3.59

6.61 ± 0.53

Group O

49.5 ± 3.70

10.72 ± 0.14

48.25 ± 3.10

10.69 ± 0.24

Group P

23.2 ± 3.83

5.93 ± 0.50

33.6 ± 3.58

8.43 ± 0.29